Universität Bielefeld Electronic Collections animiertes Foto Universität Bielefeld

Zugang zum Dokument



Legislative Background for Marketing Authorisation of the Biosimilar Medical Products in EU

Benisheva-Dimitrova, Tatyana ; Trendafilova Petya

Erschienen in: Programmes for Training on Research in Public Health for South Eastern Europe. Vol. 5: Management in Health Care Practice: A Handbook for Teachers, Researchers and Health Professionals, ed. Luka Kovačić, Lijana Zaletel-Kragelj
ISBN: 978-3-89918-175-3
Herausgeber: Luka Kovačić, Lijana Zaletel-Kragelj


Abstract:
The article presents a legislative overview of the medicinal products from biotechnological source, which are derived from living organisms so called biosimilars. Since 2004, based on Directive 2004/27/EC the term “biogeneric” does not exist any more and the therapeutic proteins including, recombinant human insulin for the treatment of diabetes, human growth hormone for the treatment of hypo-pituitary dwarfism, interferon, erythropoietin for the treatment of anaemia in cases of chronic renal failure, various blotting factors referred to an original medicinal products are called ""biosimilars"". All these biological medicinal product often heterogeneous so that modern analytical methodology could not always characterize them in terms of differences in conformation, heterogeneity and impurity profiles. Since 20 November 2005 the Marketing authorization way for biosimilars is via the Centralized Procedure pursuant Regulation (EC) 726/2004, Annex 1. In year 2006-2007 the number of the submitted medicinal product to EMEA is 14. The survey follows and discusses the issues which are necessary for the marketing authorization of all these medicinal products to prove the safety, efficacy and quality, where appropriate pre-clinical tests or clinical trials relating to these conditions must be provided.


Schlagwörter: Generic, biosimilars, biotechnological and medicinal products, biopharmaceuticals
Beteiligte Einrichtung: Fakultät für Gesundheitswissenschaften
DDC-Sachgruppe: Medizin und Gesundheit

Zitat-Vorschlag:
Benisheva-Dimitrova, Tatyana ; Trendafilova Petya  (2008)  Legislative Background for Marketing Authorisation of the Biosimilar Medical Products in EU. Programmes for Training on Research in Public Health for South Eastern Europe. Vol. 5: Management in Health Care Practice: A Handbook for Teachers, Researchers and Health Professionals, ed. Luka Kovačić, Lijana Zaletel-Kragelj 978-3-89918-175-3


URL: http://biecoll.ub.uni-bielefeld.de/volltexte/2009/2119



 Fragen und Anregungen an: publikationsdienste.ub@uni-bielefeld.de
 Letzte Änderung: 15.2.2011
 Impressum
OPUS-Logo     OAI-zertifiziert      Universitätsbibliothek Bielefeld
OAI-Logo